Research Grade Visugromab (DHJ48302);Visugromab;Research Grade Visugromab;Visugromab (anti-GDF15)
用途
Visugromab (CTL-002) is an IgG4 monoclonal antibody that neutralizes GDF-15 and exhibits synergistic anticancer activity with the anti-PD-1 antibody nivolumab (HY-P9903), demonstrating efficacy in PD-1/PD-L1 relapsed/refractory metastatic solid tumors.